Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlaytech Share News (PTEC)

Share Price Information for Playtech (PTEC)

Share Price is delayed by 15 minutes
Get Live Data
385.60    20.20 (5.53%)
Bid:
385.60
Ask:
390.00
Spread: 4.40 (1.141%)
Market Cap: £1.07b
PTEC Live PriceLast checked at - London Stock Exchange

Intraday Playtech Share Chart

Friday broker round-up

Fri, 15th Jul 2016 15:00
(ShareCast News) - Ashmore: Goldman Sachs upgrades to buy with a target price of 420p and JP Morgan reiterates underweight with a 250p target.G4S: UBS keeps at buy with a 240p target.Essentra: Jefferies reiterates buy with a 715p target.Playtech: UBS stays at buy with a 1000p target.Aberdeen: Goldman Sachs reiterates neutral with a target price of 330p.Virgin Money: Exane BNP Paribas reiterates to outperform with a target price of 360p.Thomas Cook: Jefferies keeps at buy with a 100p target.BTG: Jefferies stays at buy with a target of 860p.Lavendon: Canaccord reiterates buy with a 165p target.Ashtead: UBS stays at neutral with a 1125p target.

Related News

WINNERS & LOSERS: Vodafone and easyJet jump on deal activity
1 day ago

WINNERS & LOSERS: Vodafone and easyJet jump on deal activity

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Friday.

LONDON BROKER RATINGS: Citi and Jefferies say buy Astra after tumble
1 day ago

LONDON BROKER RATINGS: Citi and Jefferies say buy Astra after tumble

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday:

LONDON MARKET CLOSE: FTSE 100 held back by AstraZeneca trial setback
1 day ago

LONDON MARKET CLOSE: FTSE 100 held back by AstraZeneca trial setback

(Alliance News) - Heavy falls in AstraZeneca saw London's FTSE 100 underperform European peers, while investors continue to weigh developments in the ...

Playtech News

WINNERS & LOSERS: Vodafone and easyJet jump on deal activity
1 day ago

WINNERS & LOSERS: Vodafone and easyJet jump on deal activity

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Friday.

LONDON BROKER RATINGS: Citi and Jefferies say buy Astra after tumble
1 day ago

LONDON BROKER RATINGS: Citi and Jefferies say buy Astra after tumble

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday:

LONDON MARKET CLOSE: FTSE 100 held back by AstraZeneca trial setback
1 day ago

LONDON MARKET CLOSE: FTSE 100 held back by AstraZeneca trial setback

(Alliance News) - Heavy falls in AstraZeneca saw London's FTSE 100 underperform European peers, while investors continue to weigh developments in the ...

UK's FTSE 100 ticks lower as AstraZeneca drag offsets banks, mining gains
1 day ago

UK's FTSE 100 ticks lower as AstraZeneca drag offsets banks, mining gains

* FTSE 100 down 0.2%, FTSE 250 ​up ⁠1%

LONDON MARKET MIDDAY: FTSE 100 misses out on rebound as Astra drops
2 days ago

LONDON MARKET MIDDAY: FTSE 100 misses out on rebound as Astra drops

(Alliance News) - Stock prices in London were mixed at midday on Thursday, with the FTSE 100 underperforming its European peers as a sharp fall in Ast...

Playtech expects annual earnings beat despite UK regulatory pressure
2 days ago

Playtech expects annual earnings beat despite UK regulatory pressure

(Alliance News) - Playtech PLC on Thursday said it expects 2026 results to beat market expectations, with its first half supported by an "excellent pe...

WINNERS & LOSERS: Astra down on failed test; Computacenter ups outlook
2 days ago

WINNERS & LOSERS: Astra down on failed test; Computacenter ups outlook

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Thursday.

LONDON MARKET OPEN: FTSE 100 lags Europe as AstraZeneca sinks
2 days ago

LONDON MARKET OPEN: FTSE 100 lags Europe as AstraZeneca sinks

(Alliance News) - Stock prices in London opened lower on Thursday, with the FTSE 100 lagging behind its European peers as a sharp fall in AstraZeneca ...